Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.64 |
| ▸ | CXCR4 | P61073 | 11/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.64 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.64 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.64 |
| ▸ | CCR2 | P41597 | 1/20 | 0.64 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | CHKA | P35790 | 1/20 | 0.61 |
| ▸ | ACHE | P22303 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL593143 | 0.94 | SLC6A4 (0.71) | SLC6A4CXCR4KMT2AHRH3MEN1 | |
| SCHEMBL16830448 | 0.92 | SLC6A4 (0.69) | SLC6A4CXCR4KMT2AHRH3MEN1 | |
| SCHEMBL10460248 | 0.89 | SLC6A4 (0.65) | SLC6A4CXCR4KMT2AHRH3MEN1 | |
| SCHEMBL31097161 | 0.85 | KMT2A (0.77) | KMT2AHRH3MEN1CHKAACHE | |
| SCHEMBL31392631 | 0.85 | CHKA (0.79) | KMT2AHRH3MEN1CHKAACHE | |
| SCHEMBL31010303 | 0.84 | KMT2A (0.74) | KMT2AHRH3CHKAACHEPKM | |
| SCHEMBL5195380 | 0.84 | KMT2A (0.74) | KMT2AHRH3CHKAACHEPKM | |
| Hydrochloric Acid SCHEMBL16825143 | 0.82 | KMT2A (0.72) | KMT2AHRH3CHKAACHEPKM | |
| SCHEMBL27999347 | 0.82 | KMT2A (0.89) | KMT2AHRH3MEN1CHKAACHE | |
| SCHEMBL255099 | 0.80 | SIGMAR1 (0.85) | CXCR4KMT2AHRH3MEN1CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8951997-B2 | Substituted isoquinoline derivative | D. WESTERN THERAPEUTICS INSTITUTE, INC. (JP) | 2015-02-10 | — | — | US | disclosed |
| US-20120035159-A1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | D. WESTERN THERAPEUTICS INSTITUTE, INC (JP) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035159-A1 | SUBSTITUTED ISOQUINOLINE DERIVATIVE | SULT1A1, SULT1E1, SULT2A1 | SLC6A4 616/4885CXCR4 498/4885KMT2A 1007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.